<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03875274</url>
  </required_header>
  <id_info>
    <org_study_id>IRC/0832/016</org_study_id>
    <nct_id>NCT03875274</nct_id>
  </id_info>
  <brief_title>Morphine Added to Ropivacaine for FICB for Postoperative Analgesia</brief_title>
  <official_title>Postoperative Analgesic Effect of Morphine Added to Ropivacaine for Fascia Iliaca Compartment Block Following Femoral Fracture Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B.P. Koirala Institute of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B.P. Koirala Institute of Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      prospective, randomized double blinded study to investigate the effects of morphine as an
      adjuvant to ropivacaine on FICB
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of analgesia</measure>
    <time_frame>24 hours</time_frame>
    <description>The period in minutes when the patient is free of pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Requirement of postoperative opioids</measure>
    <time_frame>24 hours</time_frame>
    <description>milligram of tramadol</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numeric Rating Scale</measure>
    <time_frame>0 hour, 4 hour, 8 hour, 12 hour, 24 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ramsay Sedation Score</measure>
    <time_frame>0 hour, 4 hour, 8 hour, 12 hour, 24 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics</measure>
    <time_frame>0 hour, 4 hour, 8 hour, 12 hour, 24 hour</time_frame>
    <description>Heart rate, blood pressure</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Ropivacaine group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ropivacaine 0.375% 20 ml + Normal saline 2 ml via FICB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine and morphine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine 0.375% 20 ml + Morphine 2 ml via FICB</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine, Morphine</intervention_name>
    <description>Morphine added to ropivacaine for fascia iliaca compartment block</description>
    <arm_group_label>Ropivacaine and morphine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine, Saline</intervention_name>
    <description>Normal saline added to ropivacaine for fascia iliaca compartment block</description>
    <arm_group_label>Ropivacaine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients undergoing elective femur surgery under spinal anaesthesia

               -  Age group (18-65 years)

               -  ASA physical status I and II

        Exclusion Criteria:

          -  • Not willing to participate in the study

               -  Other painful co-morbidities (neuropathies)

               -  Allergy or any contraindication to study medication

               -  Psychiatric disorder

               -  Coagulopathy

               -  Infection at the site of the block

               -  Use of other modes of anaesthesia or analgesia besides spinal anaesthesia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>BPKIHS</name>
      <address>
        <city>Dharān Bāzār</city>
        <state>Sunsari</state>
        <zip>977</zip>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 1, 2019</study_first_submitted>
  <study_first_submitted_qc>March 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2019</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>B.P. Koirala Institute of Health Sciences</investigator_affiliation>
    <investigator_full_name>Pankaj Baral</investigator_full_name>
    <investigator_title>Junior Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

